Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,225,000 | 270,123 | 372,152 | 208,130 | 395,203 |
| Marketable Securities | 1,140,000 | 1,394,982 | 1,139,620 | 826,442 | 952,875 |
| Receivables | 1,050,000 | 959,955 | 597,397 | 418,481 | 315,340 |
| Inventories | 703,000 | 590,343 | 469,640 | 393,542 | 356,946 |
| Income taxes - deferred | 167,000 | 148,370 | 121,885 | 82,299 | 139,567 |
| Other current assets | 0 | 0 | 0 | 103,148 | 22,567 |
| TOTAL | $4,386,000 | $3,425,340 | $2,780,136 | $2,082,784 | $2,221,394 |
| Non-Current Assets | |||||
| PPE Net | 3,349,000 | 2,091,404 | 1,617,912 | 1,068,734 | 865,668 |
| Investments And Advances | 1,449,000 | 1,115,327 | 1,422,886 | 567,286 | 1,516,813 |
| Intangibles | 1,889,000 | 1,983,410 | 2,125,829 | 2,242,557 | 2,415,792 |
| Other Non-Current Assets | 1,074,000 | 787,914 | 812,714 | 796,758 | 127,222 |
| TOTAL | $7,761,000 | $5,978,055 | $5,979,341 | $4,675,335 | $4,925,495 |
| Total Assets | $12,147,000 | $9,403,395 | $8,759,477 | $6,758,119 | $7,146,889 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 149,692 |
| Accounts payable and accrued liabilities | 339,000 | 104,832 | 59,700 | 51,380 | 33,348 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 45,259 |
| TOTAL | $1,660,000 | $1,238,030 | $896,337 | $646,660 | $663,797 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,083,000 | 412,250 | 412,250 | N/A | N/A |
| Deferred Revenues | 44,000 | 45,989 | 47,478 | 20,044 | 19,543 |
| Other Non-Current Liabilities | 714,000 | 703,120 | 649,349 | 554,728 | 47,431 |
| TOTAL | $3,017,000 | $1,383,175 | $1,342,842 | $772,575 | $563,273 |
| Total Liabilities | $4,677,000 | $2,621,205 | $2,239,179 | $1,419,235 | $1,227,070 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053,872 | 1,046,300 | 1,054,058 | 1,025,156 | 1,055,588 |
| Common Shares | 21,000 | 20,943 | 20,990 | 10,256 | 10,566 |
| Retained earnings | -2,067,000 | -1,532,455 | -1,157,141 | -1,590,366 | -1,197,300 |
| Other shareholders' equity | 253,000 | 290,948 | 297,033 | 268,642 | 311,722 |
| TOTAL | $7,470,000 | $6,782,190 | $6,520,298 | $5,338,884 | $5,919,819 |
| Total Liabilities And Equity | $12,147,000 | $9,403,395 | $8,759,477 | $6,758,119 | $7,146,889 |